Rituximab Improves Clinical Outcomes of CAR-T Therapy for r/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion

被引：2

作者：

Li, Yangzi ^{[1
]}

Liu, Sining ^{[2
]}

Cui, Qingya ^{[3
]}

Liu, Lingling ^{[1
]}

Li, Zheng ^{[3
]}

Cui, Wei ^{[3
]}

Li, Mengyun ^{[3
]}

Zhu, Xiaming ^{[3
]}

Kang, Liqing ^{[4
]}

Yu, Lei ^{[4
]}

Wu, Depei ^{[5
]}

Tang, Xiaowen ^{[3
]}

机构：

[1] Soochow Univ, Affifiliated Hosp 1, Suzhou, Peoples R China

[2] Soochow Univ, Affifiliated Hosp 1, Suzhou, Peoples R China

[3] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China

[4] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China

[5] Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Collaborat Innovat Ctr Hematol,Affiliated Hosp 1, Suzhou, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184505

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion
Li, Yangzi
Cui, Qingya
Liu, Sining
Liu, Lingling
Li, Megyn
Gao, Jun
Li, Zheng
Cui, Wei
Zhu, Xiaming
Kang, Liqing
Yu, Lei
Wu, Depei
Tang, Xiaowen
CELLULAR ONCOLOGY, 2024, 47 (5) : 1649 - 1661
[2] Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T
Li, Shiqi
Zhang, Jiasi
Chen, Lvzhe
Xu, Huailong
He, Liping
Liu, Lin
Zhang, Qianzhen
Yuan, Zhongtao
Shen, Junjie
Chen, Zucong
Zhang, Yingzi
Wang, Meiling
Li, Yunyan
Wang, Linling
Fang, Lihua
Chen, Yingnian
Zhu, Wei
Li, Yu
Luo, Le
Wang, Youcheng
Zhang, Dingsong
Dong, Yancheng
Yin, Ping
Zhang, Lihua
Li, Xiaoping
Hu, Xiaozhuang
Zheng, Zhongzheng
Yang, Zhi
Qian, Cheng
Wang, Sanbin
MOLECULAR THERAPY-ONCOLYTICS, 2023, 29 : 107 - 117
[3] Functional diversification and dynamics of CAR-T cells in patients with B-ALL
Li, Zongcheng
Zhao, Lei
Zhang, Yuanyuan
Zhu, Li
Mu, Wei
Ge, Tong
Jin, Jin
Tan, Jiaqi
Cheng, Jiali
Wang, Jue
Wang, Na
Zhou, Xiaoxi
Chen, Liting
Chang, Zhilin
Liu, Chen
Bian, Zhilei
Liu, Bing
Ye, Lilin
Lan, Yu
Huang, Liang
Zhou, Jianfeng
CELL REPORTS, 2023, 42 (10):
[4] Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients
Li, Zongcheng
Zhao, Lei
Zhang, Yuanyuan
Zhu, Li
Mu, Wei
Ge, Tong
Jin, Jin
Tan, Jiaqi
Cheng, Jiali
Wang, Jue
Wang, Na
Zhou, Xiaoxi
Chen, Liting
Chang, Zhilin
Liu, Chen
Bian Zhilei
Liu, Bing
Ye, Lilin
Lan, Yu
Huang, Liang
BLOOD, 2023, 142
[5] Clinical pharmacology of CAR-T cells
Bondanza, A.
HUMAN GENE THERAPY, 2016, 27 (11) : A6 - A6
[6] CAR-T therapy as a consolidation in remission B-ALL patients with poor prognosis
Yin, Zhichao
Lin, Yuehui
Liu, Dan
Tong, Chunrong
Liu, Shuangyou
CANCER REPORTS, 2022, 5 (10)
[7] CAR-T therapy for leukemia: progress and challenges
Wang, Xin
Xiao, Qing
Wang, Zhe
Feng, Wen-Li
TRANSLATIONAL RESEARCH, 2017, 182 : 135 - 144
[8] Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Bulliard, Yannick
Andersson, Borje S.
Baysal, Mehmet A.
Damiano, Jason
Tsimberidou, Apostolia M.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
[9] Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard
Borje S. Andersson
Mehmet A. Baysal
Jason Damiano
Apostolia M. Tsimberidou
Journal of Hematology & Oncology, 16
[10] Efficacy and influencing factors of CD19 CAR-T cell therapy for children and adults with r/r B-ALL
An, F.
Liu, Z.
Wu, F.
Wang, H.
Zhang, J.
Cheng, F.
Tao, Q.
Li, Y.
Shen, Y.
Ruan, Y.
Zhang, Q.
Pan, Y.
Zhu, W.
Wang, W.
Xu, H.
Qin, H.
Wang, Y.
Feng, Z.
Song, X.
Zhai, Z.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1717 - 1717

← 1 2 3 4 5 →